Biological Threats and Terrorism: Assessing the Science and Response Capabilities: Workshop Summary

Front Cover
National Academies Press, Mar 7, 2002 - Political Science - 336 pages
0 Reviews

In the wake of September 11th and recent anthrax events, our nationā€™s bioterrorism response capability has become an imminent priority for policymakers, researchers, public health officials, academia, and the private sector. In a three-day workshop, convened by the Institute of Medicineā€™s Forum on Emerging Infections, experts from each of these communities came together to identify, clarify, and prioritize the next steps that need to be taken in order to prepare and strengthen bioterrorism response capabilities. From the discussions, it became clear that of utmost urgency is the need to cast the issue of a response in an appropriate framework in order to attract the attention of Congress and the public in order to garner sufficient and sustainable support for such initiatives. No matter how the issue is cast, numerous workshop participants agreed that there are many gaps in the public health infrastructure and countermeasure capabilities that must be prioritized and addressed in order to assure a rapid and effective response to another bioterrorist attack.

 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

Summary and Assessment
1
1 Introduction
20
2 Assessing Our Understanding of the Threats
43
Research Development Production and Procurement Issues
85
Implications for Therapeutic Countermeasures to Biological Threats
113
5 Assessing the Capacity of the Public Health Infrastructure
148
6 Scientific and Policy Tools for Countering Bioterrorism
182
How Prepared Are We? Assessing the Science and Our Response Capabilities
220
Appendix D Summary of the FristKennedy Bioterrorism Preparedness Act of 2001
239
Food and Drug Administration Docket No 01N0494
244
Appendix F Veterans AffairsDepartment of Defense Contingency
252
Appendix G The Model State Emergency Health Powers Act
254
Assessment of Local Bioterrorism and Emergency Preparedness
257
Appendix I Statement on Vaccine Development
262
Appendix J Testimony of Kenneth I Shine MD
269
Appendix K Glossary and Acronyms
275

Appendix B Information Resources
225
Appendix C Testimony of Joshua Lederberg PhD
235
Appendix L Forum Member Speaker and Staff Biographies
287
Copyright

Other editions - View all

Common terms and phrases

Bibliographic information